If your medication is discontinued just after attaining fat reduction, a risk of rebound fat gain exists. This was demonstrated within an extension of your STEP 1 demo, where by participants, after discontinuing weekly subcutaneous semaglutide two.2016). Regardless of the nebulous relationship among GIP and inflammation, this evidence might suggest